Vertex Pharmaceuticals Inc / Ma
VRTXNasdaqCIK 875320HealthcareFiscal year ends Dec 31
Reports and events: 289 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2013-08-0220:02 ET | 10-Q | Quarterly reportPeriod 2013-06-30 | 0000875320-13-000038 |
| 2013-07-2920:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-13-000036 |
| 2013-05-1712:41 ET | 8-K | 2.04 Item not in the standard list; 3.02 Unregistered sale of equity; 8.01 Other events | 0000875320-13-000027 |
| 2013-05-0820:35 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000875320-13-000025 |
| 2013-05-0820:33 ET | 10-Q | Quarterly reportPeriod 2013-03-31 | 0000875320-13-000024 |
| 2013-04-3020:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-13-000019 |
| 2013-04-0421:23 ET | DEF 14A | Proxy statementPeriod 2013-05-08 | 0000875320-13-000013 |
| 2013-03-0121:01 ET | 10-K | Annual reportPeriod 2012-12-31 | 0000875320-13-000009 |
| 2013-02-1121:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000875320-13-000003 |
| 2013-01-2921:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-13-005550 |
| 2012-11-0621:32 ET | 10-Q | Quarterly reportPeriod 2012-09-30 | 0001047469-12-010125 |
| 2012-11-0120:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-12-073222 |
| 2012-09-2020:44 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-12-064604 |
| 2012-09-0720:15 ET | 10-Q/A | Quarterly report, amendedPeriod 2008-06-30 | 0001104659-12-062275 |
| 2012-08-0820:31 ET | 10-Q | Quarterly reportPeriod 2012-06-30 | 0001047469-12-007979 |
| 2012-07-3020:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-12-052252 |
| 2012-06-0820:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-12-042599 |
| 2012-05-2920:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-12-040394 |
| 2012-05-1720:10 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results | 0001104659-12-038145 |
| 2012-05-1020:17 ET | 10-Q | Quarterly reportPeriod 2012-03-31 | 0001047469-12-005755 |
| 2012-04-2620:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-12-029068 |
| 2012-04-1020:13 ET | DEF 14A | Proxy statementPeriod 2012-05-16 | 0001047469-12-004110 |
| 2012-03-0221:34 ET | 10-Q/A | Quarterly report, amendedPeriod 2011-06-30 | 0001410578-12-000068 |
| 2012-02-2222:08 ET | 10-K | Annual reportPeriod 2011-12-31 | 0001047469-12-001298 |
| 2012-02-0221:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-12-006229 |
| 2012-01-3121:16 ET | 8-K | 8.01 Other events | 0001104659-12-005497 |
| 2011-12-1621:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-11-069922 |
| 2011-11-0321:16 ET | 10-Q | Quarterly reportPeriod 2011-09-30 | 0001047469-11-009007 |
| 2011-10-2720:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-11-058469 |
| 2011-09-2013:25 ET | 8-K | 8.01 Other events | 0001104659-11-052438 |
| 2011-08-3012:50 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-11-049325 |
| 2011-08-2212:01 ET | 8-K | 8.01 Other events | 0001104659-11-048062 |
| 2011-08-1920:15 ET | 10-Q/A | Quarterly report, amendedPeriod 2011-06-30 | 0001104659-11-047955 |
| 2011-08-0920:13 ET | 10-Q | Quarterly reportPeriod 2011-06-30 | 0001047469-11-007153 |
| 2011-07-2820:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-11-041536 |
| 2011-06-1720:15 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-11-035399 |
| 2011-05-2320:31 ET | 8-K | 8.01 Other events | 0001104659-11-030854 |
| 2011-05-1820:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.05 Item not in the standard list; 5.07 Shareholder vote results | 0001104659-11-029955 |
| 2011-05-0620:18 ET | 10-Q | Quarterly reportPeriod 2011-03-31 | 0001047469-11-004721 |
| 2011-05-0514:03 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-11-026088 |
| 2011-05-0320:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-11-025328 |
| 2011-04-0813:00 ET | DEF 14A | Proxy statementPeriod 2011-05-12 | 0001047469-11-003402 |
| 2011-04-0712:03 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-11-019015 |
| 2011-03-0121:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-11-011477 |
| 2011-02-1721:37 ET | 10-K | Annual reportPeriod 2010-12-31 | 0001047469-11-001025 |
| 2011-02-0322:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-11-004832 |
| 2011-01-1321:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-11-001423 |
| 2011-01-1016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-11-000931 |
| 2010-10-2820:53 ET | 10-Q | Quarterly reportPeriod 2010-09-30 | 0001047469-10-008963 |
| 2010-10-2520:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-10-053530 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 12:56 ET. Listed shows no prices and gives no investment advice.